eMagin, the OLED microdisplay maker, reported their financial results for Q2 2014. Revenues were $7 million (the same as in Q2 2013), while net loss was $1 million (the same again as in Q2 2013).

eMagin XGA096 OLED-XL photoeMagin XGA096 OLED-XL

While the company's financial results are still not very impressive, they do report significant advances in their R&D programs, mainly for ultra high-brightness displays and direct-patterned panels. In the near term, they hope that new R&D projects will help them increase revenues. In the long term, they seem certain that the advantages of direct-emission displays will enable them to achieve design wins in future commercial wearable devices such as HMDs.

eMagin has about $5.6 million in cash or equivalents, down from $8.3 million in the end of March 2014. The company however hopes to return to profitability soon.

Sources: Seeking Alpha



Disclosure: the author of this post holds shares in eMagin

Tags:
Cambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDsCambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDs